This is a correction notice to a review that revisits Parkinson’s disease definition and classification using two emerging biological frameworks and does not present new experimental data or direct therapeutic findings.

Although the correction itself offers little actionable therapeutic information, refined conceptual frameworks can still help align biomarker-based patient stratification and research priorities that indirectly support future drug discovery efforts.